VORCAN
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

VORCAN Trademark

Serial Number: 77323593 • Registration: 3756464

VORCAN is a trademark filed by YUNG SHIN PHARMACEUTICAL IND. CO., LTD. on November 7, 2007. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

YUNG SHIN PHARMACEUTICAL IND. CO., LTD. (3 trademarks)

No. 1191, Sec. 1, Chung Shan Rd, Tachia
Taichung , TW

Entity Type: 03

Trademark Details

Filing Date

November 7, 2007

Registration Date

March 9, 2010

Published for Opposition

December 22, 2009

Cancellation Date

October 14, 2016

Goods & Services

medicines for human purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; drugs for medical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; pharmaceutical preparations for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; pills for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; pastilles for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; powder for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; capsules for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; ointments for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; analgesic preparations; oral analgesics; anti-inflammatories; oral anti-inflammatories; anesthetics for non-surgical use; anti-arthritic compositions and preparations; medicines for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; drugs and pharmaceutical preparations for human purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; antibiotic ointments, anti-inflammatory ointments, anti-itch ointments, pain relief ointments, antifungal creams for medical use; analgesic anti-inflammatory preparations; analgesics anti-inflammatory patches; nutritional supplements

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 14, 2016 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 21, 2016 TCCA
REGISTERED-PRINCIPAL REGISTER
Mar 9, 2010 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 22, 2009 NPUB
PUBLISHED FOR OPPOSITION
Dec 22, 2009 PUBO
NOTICE OF ALLOWANCE CANCELLED
Nov 18, 2009 IUCN
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Nov 18, 2009 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Nov 18, 2009 PCBG
ASSIGNED TO PETITION STAFF
Nov 16, 2009 APET
SOU EXTENSION 2 GRANTED
Nov 2, 2009 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 2, 2009 AITU
PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Oct 9, 2009 PDCB
FAX RECEIVED
Oct 9, 2009 FAXX
SOU EXTENSION 2 FILED
Oct 7, 2009 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 7, 2009 EEXT
SOU EXTENSION 1 GRANTED
Mar 3, 2009 EX1G
SOU EXTENSION 1 FILED
Mar 3, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 3, 2009 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 7, 2008 NOAM
PUBLISHED FOR OPPOSITION
Jul 15, 2008 PUBO
NOTICE OF PUBLICATION
Jun 25, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 9, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 9, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 9, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 9, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 9, 2008 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 4, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 2, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 19, 2008 PREV
ASSIGNED TO LIE
May 19, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 15, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2008 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2008 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2008 CNRT
ASSIGNED TO EXAMINER
Feb 21, 2008 DOCK
NEW APPLICATION ENTERED
Nov 13, 2007 NWAP